Targeting cancer stem cells in glioblastoma multiforme using mTOR inhibitors and the differentiating agent all-trans retinoic acid
Marissa Rybstein(New York Medical College), Meena Jhanwar‐Uniyal(Westchester Medical Center)
Cited by 49
Related Papers
Targeting the mTOR pathway using novel ATP‑competitive inhibitors, Torin1, Torin2 and XL388, in the treatment of glioblastoma
|International Journal of Oncology|2021|29
Molecular Sequence of Events and Signaling Pathways in Cerebral Metastases
|Anticancer Research|2018|12